HMGN3_RAT
ID HMGN3_RAT Reviewed; 95 AA.
AC Q66H40;
DT 18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT 11-OCT-2004, sequence version 1.
DT 03-AUG-2022, entry version 105.
DE RecName: Full=High mobility group nucleosome-binding domain-containing protein 3;
GN Name=Hmgn3;
OS Rattus norvegicus (Rat).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Rattus.
OX NCBI_TaxID=10116;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Kidney;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [2]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY MASS
RP SPECTROMETRY [LARGE SCALE ANALYSIS].
RX PubMed=22673903; DOI=10.1038/ncomms1871;
RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA Olsen J.V.;
RT "Quantitative maps of protein phosphorylation sites across 14 different rat
RT organs and tissues.";
RL Nat. Commun. 3:876-876(2012).
CC -!- FUNCTION: Binds to nucleosomes, regulating chromatin structure and
CC consequently, chromatin-dependent processes such as transcription, DNA
CC replication and DNA repair. Affects both insulin and glucagon levels
CC and modulates the expression of pancreatic genes involved in insulin
CC secretion. Regulates the expression of the glucose transporter SLC2A2
CC by binding specifically to its promoter region and recruiting PDX1 and
CC additional transcription factors. Regulates the expression of SLC6A9, a
CC glycine transporter which regulates the glycine concentration in
CC synaptic junctions in the central nervous system, by binding to its
CC transcription start site. May play a role in ocular development and
CC astrocyte function (By similarity). {ECO:0000250}.
CC -!- SUBUNIT: Interacts with the ligand binding domain of the thyroid
CC receptor (TR) (in vitro). Requires the presence of thyroid hormone for
CC its interaction. Interacts with transcriptional regulator SEHBP.
CC Interacts with nucleosomes. {ECO:0000250|UniProtKB:Q15651}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the HMGN family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC082036; AAH82036.1; -; mRNA.
DR RefSeq; NP_001007021.1; NM_001007020.2.
DR RefSeq; NP_001188282.1; NM_001201353.1.
DR RefSeq; NP_001188283.1; NM_001201354.1.
DR RefSeq; NP_001188284.1; NM_001201355.1.
DR AlphaFoldDB; Q66H40; -.
DR BioGRID; 250246; 2.
DR STRING; 10116.ENSRNOP00000066015; -.
DR iPTMnet; Q66H40; -.
DR PhosphoSitePlus; Q66H40; -.
DR PaxDb; Q66H40; -.
DR GeneID; 113990; -.
DR KEGG; rno:113990; -.
DR UCSC; RGD:1359106; rat.
DR CTD; 9324; -.
DR RGD; 1359106; Hmgn3.
DR eggNOG; ENOG502S60V; Eukaryota.
DR InParanoid; Q66H40; -.
DR OrthoDB; 1617797at2759; -.
DR PhylomeDB; Q66H40; -.
DR PRO; PR:Q66H40; -.
DR Proteomes; UP000002494; Chromosome 8.
DR Bgee; ENSRNOG00000031032; Expressed in cerebellum and 20 other tissues.
DR ExpressionAtlas; Q66H40; baseline and differential.
DR Genevisible; Q66H40; RN.
DR GO; GO:0000785; C:chromatin; IEA:InterPro.
DR GO; GO:0005634; C:nucleus; ISO:RGD.
DR GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR GO; GO:0031492; F:nucleosomal DNA binding; IEA:InterPro.
DR GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISO:RGD.
DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISO:RGD.
DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR InterPro; IPR031073; HMGN3.
DR InterPro; IPR000079; HMGN_fam.
DR PANTHER; PTHR23087:SF2; PTHR23087:SF2; 1.
DR Pfam; PF01101; HMG14_17; 1.
DR PRINTS; PR00925; NONHISHMG17.
DR SMART; SM00527; HMG17; 1.
DR PROSITE; PS00355; HMG14_17; 1.
PE 1: Evidence at protein level;
KW Chromatin regulator; DNA-binding; Nucleus; Phosphoprotein;
KW Reference proteome.
FT CHAIN 1..95
FT /note="High mobility group nucleosome-binding domain-
FT containing protein 3"
FT /id="PRO_0000232577"
FT REGION 1..95
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1..27
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 38..72
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOD_RES 6
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:22673903"
FT MOD_RES 78
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q15651"
SQ SEQUENCE 95 AA; 10183 MW; FCC76474258624B7 CRC64;
MPKRKSPENA EGKDGAKLTK QEPTRRSARL SAKPVPPKPE PKPRKTSAKK EPGTKINRAA
KGKKEEKQEA GKEGTAPSAN GDTKAEEVLS TNASH